Refresh
Exchange Announcement • 22 Aug 2024 16:10
Exchange Announcement • 22 Aug 2024 15:23
Exchange Announcement • 22 Aug 2024 14:42
Exchange Announcement • 22 Aug 2024 14:41
Exchange Announcement • 22 Aug 2024 14:40
ENTITY
Telix Pharmaceuticals (TLX AU)
Telix Pharmaceuticals (TLX AU)
42
Analysis
Health Care • Australia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
x